Position in GSK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$53,439,516
+$53,439,516 QoQ
Shares Held
1,019,449
Ownership
0.051%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#41
of 1,033 holders
Holding Since
Mar 2020
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Derivatives in GSK
reported options exposure · as of Jun 30, 2026CallValue
$3,491,172
CallShares
66,600
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026D. E. Shaw & Co., Inc. holds $2,890,989,313 across 13 Drug Manufacturers - General names. GSK ranks #9 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
496,563 | $595,592,608 | |
| 2 | ABBV |
AbbVie Inc.
|
2,102,316 | $529,026,797 | |
| 3 | AMGN |
Amgen Inc
|
1,290,217 | $467,213,379 | |
| 4 | MRK |
Merck & Co., Inc.
|
2,738,023 | $351,835,955 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
2,294,789 | $289,923,642 | |
| 6 | AZN |
Astrazeneca PLC
|
1,094,593 | $207,556,724 | |
| 7 | JNJ |
Johnson & Johnson
|
687,227 | $174,535,041 | |
| 8 | PFE |
Pfizer Inc
|
5,414,297 | $130,376,270 |
All Filings in GSK
Export CSV
28 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,491,172 | 66,600 | Call | Defined | 2026-08-14 | |
| 2026-06-30 | $53,439,516 | 1,019,449 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,606,029 | 29,100 | Call | Defined | 2026-05-15 | |
| 2025-12-31 | $271,877 | 5,544 | Shares | Defined | 2026-02-17 | |
| 2025-03-31 | $3,978,598 | 102,700 | Call | Defined | 2025-05-15 | |
| 2024-12-31 | $3,859,200 | 114,110 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $5,022,353 | 122,856 | Shares | Defined | 2024-11-14 | |
| 2023-09-30 | $913,500 | 25,200 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $7,828,718 | 219,661 | Shares | Defined | 2023-08-14 | |
| 2022-12-31 | $1,950,270 | 55,500 | Put | Defined | 2023-02-14 | |
| 2022-09-30 | $3,178,440 | 108,000 | Put | Defined | 2022-11-14 | |
| 2022-06-30 | $2,134,711 | 50,000 | Put | Defined | 2022-08-15 | |
| 2022-06-30 | $5,027,671 | 117,760 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $21,572,750 | 504,937 | Shares | Defined | 2022-05-16 | |
| 2022-03-31 | $3,845,128 | 90,000 | Put | Defined | 2022-05-16 | |
| 2021-12-31 | $3,027,729 | 70,000 | Put | Defined | 2022-02-14 | |
| 2021-12-31 | $31,740,554 | 733,830 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $550,490 | 14,689 | Shares | Defined | 2021-11-15 | |
| 2021-09-30 | $2,679,560 | 71,500 | Put | Defined | 2021-11-15 | |
| 2021-06-30 | $379,814 | 9,725 | Shares | Defined | 2021-08-16 | |
| 2021-06-30 | $3,964,128 | 101,500 | Put | Defined | 2021-08-16 | |
| 2021-03-31 | $1,956,765 | 55,900 | Put | Defined | 2021-05-17 | |
| 2021-03-31 | $1,750,237 | 50,000 | Call | Defined | 2021-05-17 | |
| 2020-12-31 | $1,364,332 | 37,800 | Put | Defined | 2021-02-16 | |
| 2020-12-31 | $2,004,810 | 55,545 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $28,870,814 | 782,040 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $5,473,454 | 136,813 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $31,273,108 | 841,523 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||